4-((5-Bromopyridin-2-yl)oxy)phenol

Catalog No.: 
ACBSGT726
CAS No.: 
75053-81-5
Molecular Formula: 
C11H8BrNO2
Molecular Weight: 
266.09
4-((5-Bromopyridin-2-yl)oxy)phenol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$211.00InquiryInquiry
100mg98%$303.00InquiryInquiry
250mg98%$426.00InquiryInquiry
1g98%$849.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((5-Bromopyridin-2-yl)oxy)phenol
IUPAC Name4-((5-bromopyridin-2-yl)oxy)phenol
MDL No.MFCD12763650
Molecular FormulaC11H8BrNO2
Molecular Weight266.09
SMILESOC1=CC=C(OC2=NC=C(Br)C=C2)C=C1
InChI KeyITZCGYJQNYTOIP-UHFFFAOYSA-N
Synonym4-[(5-bromopyridin-2-yl)oxy]phenol;Phenol, 4-[(5-bromo-2-pyridinyl)oxy]-;4-[(5-Bromo-2-pyridinyl)oxy]phenol
CAS No.75053-81-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBSGT726 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYIHU365 route compound structure diagram
    ACYIHU36553939-30-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBSGT726 route product structure diagram
    ACBSGT72675053-81-5
Inquiry

2. ACBSGT726 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCKWO017 route compound structure diagram
    ACCKWO017624-28-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBSGT726 route product structure diagram
    ACBSGT72675053-81-5
Inquiry

3. ACBSGT726 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBSGT726 route product structure diagram
    ACBSGT72675053-81-5
Inquiry

Comments (0)